(+)-alpha-viniferin multiple interactions ISO RGD:736024 6480464 alpha-viniferin inhibits the reaction [MAPK9 protein results in increased phosphorylation of and results in increased activity of STAT1 protein] CTD PMID:20424383 (-)-anisomycin multiple interactions ISO RGD:736024 6480464 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3, 4-d)pyrimidine inhibits the reaction [Anisomycin results in increased phosphorylation of MAPK9 protein] CTD PMID:15772366 (-)-anisomycin increases phosphorylation ISO RGD:736024 6480464 Anisomycin results in increased phosphorylation of MAPK9 protein CTD PMID:15772366 , PMID:16038797 (-)-anisomycin increases phosphorylation ISO RGD:736023 6480464 Anisomycin results in increased phosphorylation of MAPK9 protein CTD PMID:12967334 , PMID:33075463 (-)-citrinin increases phosphorylation ISO RGD:736023 6480464 Citrinin results in increased phosphorylation of MAPK9 protein CTD PMID:19361540 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:736023 6480464 epigallocatechin gallate inhibits the reaction [[Paclitaxel co-treated with F2 protein] results in increased phosphorylation of MAPK9 protein] CTD PMID:19944065 (R)-noradrenaline multiple interactions ISO RGD:736024 6480464 MAPK10 protein affects the reaction [MAPK9 protein affects the susceptibility to Norepinephrine] CTD PMID:16949803 (R)-noradrenaline affects response to substance ISO RGD:736024 6480464 MAPK9 protein affects the susceptibility to Norepinephrine CTD PMID:16949803 (R,R,R)-alpha-tocopherol increases phosphorylation ISO RGD:736023 6480464 alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein CTD PMID:20686688 (R,R,R)-alpha-tocopherol multiple interactions ISO RGD:736023 6480464 benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein], salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein] CTD PMID:20686688 (S)-colchicine increases phosphorylation ISO RGD:736023 6480464 Colchicine results in increased phosphorylation of MAPK9 protein CTD PMID:12221076 (S)-colchicine multiple interactions ISO RGD:736023 6480464 TP53 protein affects the reaction [Colchicine results in increased phosphorylation of MAPK9 protein] CTD PMID:12221076 (S)-naringenin increases phosphorylation ISO RGD:736023 6480464 naringenin results in increased phosphorylation of MAPK9 protein CTD PMID:27838343 (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of MAPK9 mRNA CTD PMID:26776438 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane multiple interactions ISO RGD:736023 6480464 pyrazolanthrone inhibits the reaction [o, p'-DDT results in increased phosphorylation of MAPK9 protein] CTD PMID:20678559 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases phosphorylation ISO RGD:736023 6480464 o, p'-DDT results in increased phosphorylation of MAPK9 protein CTD PMID:20678559 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane multiple interactions ISO RGD:736024 6480464 o more ... CTD PMID:18840457 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose multiple interactions ISO RGD:736024 6480464 beta-penta-O-galloyl-glucose inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased phosphorylation of MAPK9 protein], beta-penta-O-galloyl-glucose inhibits the reaction [TNF protein results in increased phosphorylation of MAPK9 protein] CTD PMID:30721698 1,2-dimethylhydrazine increases expression ISO RGD:736024 6480464 1, 2-Dimethylhydrazine results in increased expression of MAPK9 mRNA CTD PMID:22206623 1,3-dichloropropan-2-ol increases phosphorylation EXP 6480464 1, 3-dichloro-2-propanol results in increased phosphorylation of MAPK9 protein CTD PMID:26143167 1,3-dichloropropan-2-ol multiple interactions ISO RGD:736024 6480464 Acetylcysteine inhibits the reaction [1, 3-dichloro-2-propanol results in increased phosphorylation of MAPK9 protein] CTD PMID:29248572 1,3-dichloropropan-2-ol increases phosphorylation ISO RGD:736024 6480464 1, 3-dichloro-2-propanol results in increased phosphorylation of MAPK9 protein CTD PMID:29248572 1,4-phenylenediamine increases phosphorylation ISO RGD:736023 6480464 4-phenylenediamine results in increased phosphorylation of MAPK9 protein CTD PMID:23172806 1,8-cineole multiple interactions ISO RGD:736023 6480464 Eucalyptol inhibits the reaction [Lipopolysaccharides results in decreased expression of and results in decreased phosphorylation of MAPK9 protein] CTD PMID:23872422 1-fluoro-2,4-dinitrobenzene increases phosphorylation ISO RGD:736023 6480464 Dinitrofluorobenzene results in increased phosphorylation of MAPK9 protein CTD PMID:27129696 1-fluoro-2,4-dinitrobenzene multiple interactions ISO RGD:736023 6480464 Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK9 protein] CTD PMID:27129696 17beta-estradiol decreases expression ISO RGD:736023 6480464 Estradiol results in decreased expression of MAPK9 mRNA CTD PMID:23094148 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of MAPK9 mRNA CTD PMID:26496021 17beta-estradiol multiple interactions ISO RGD:736023 6480464 IGF1R mutant form inhibits the reaction [Estradiol results in decreased expression of MAPK9 mRNA] CTD PMID:23094148 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:736023 6480464 APOE gene polymorphism affects the reaction [Dihydrotestosterone affects the phosphorylation of MAPK9 protein] CTD PMID:17395708 2,3',4,4',5-Pentachlorobiphenyl multiple interactions EXP 6480464 MAPK9 affects the reaction [2 more ... CTD PMID:26519956 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:736024 6480464 Tetrachlorodibenzodioxin affects the expression of MAPK9 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAPK9 mRNA CTD PMID:34747641 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO RGD:736024 6480464 [Trinitrobenzenesulfonic Acid results in increased expression of MAPK9 protein] promotes the reaction [BCL2L11 protein binds to MAPK9 protein] more ... CTD PMID:22427801 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:736024 6480464 Trinitrobenzenesulfonic Acid results in increased expression of MAPK9 protein CTD PMID:22427801 2-methyl-6-(phenylethynyl)pyridine multiple interactions ISO RGD:736024 6480464 6-methyl-2-(phenylethynyl)pyridine promotes the reaction [Biological Products results in increased phosphorylation of MAPK9 protein] CTD PMID:29458170 3,3',5,5'-tetrabromobisphenol A multiple interactions ISO RGD:736023 6480464 Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK9 protein], diphenyleneiodonium inhibits the reaction [tetrabromobisphenol A results in increased phosphorylation of MAPK9 protein] CTD PMID:30766661 3,3',5,5'-tetrabromobisphenol A increases phosphorylation ISO RGD:736023 6480464 tetrabromobisphenol A results in increased phosphorylation of MAPK9 protein CTD PMID:30766661 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:736024 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of MAPK9 mRNA CTD PMID:26251327 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:736024 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased phosphorylation of MAPK9 protein, beta-penta-O-galloyl-glucose inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased phosphorylation of MAPK9 protein] CTD PMID:30721698 3-O-Caffeoyl-1-O-methylquinic acid increases phosphorylation ISO RGD:736023 6480464 3-O-caffeoyl-1-methylquinic acid results in increased phosphorylation of MAPK9 protein CTD PMID:16631525 3-phenylprop-2-enal multiple interactions ISO RGD:736024 6480464 cinnamaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK9 protein] CTD PMID:17868967 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid multiple interactions ISO RGD:736024 6480464 4 more ... CTD PMID:19815690 4-hydroxynon-2-enal increases phosphorylation ISO RGD:736023 6480464 4-hydroxy-2-nonenal results in increased phosphorylation of MAPK9 protein CTD PMID:24825450 4-hydroxyphenyl retinamide multiple interactions ISO RGD:736023 6480464 [IL24 protein co-treated with Fenretinide] results in increased phosphorylation of MAPK9 protein CTD PMID:15580305 4-nonylphenol increases phosphorylation ISO RGD:736024 6480464 4-nonylphenol analog results in increased phosphorylation of MAPK9 protein CTD PMID:27086933 4-phenylbutyric acid multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Cytotoxins results in increased phosphorylation of MAPK9 protein] CTD PMID:21147958 5-aza-2'-deoxycytidine decreases expression ISO RGD:736024 6480464 Decitabine results in decreased expression of MAPK9 mRNA CTD PMID:27915011 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of MAPK9 mRNA CTD PMID:18077114 acetaldehyde increases phosphorylation ISO RGD:736023 6480464 Acetaldehyde results in increased phosphorylation of MAPK9 protein CTD PMID:19110045 acetaldehyde multiple interactions ISO RGD:736023 6480464 Hesperidin inhibits the reaction [Acetaldehyde results in increased phosphorylation of MAPK9 protein] CTD PMID:19110045 acetaldehyde increases activity EXP 6480464 Acetaldehyde results in increased activity of MAPK9 protein CTD PMID:10733585 acrylamide multiple interactions ISO RGD:736024 6480464 Acetylcysteine inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK9 protein], pyrazolanthrone inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK9 protein] CTD PMID:25531190 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of MAPK9 protein modified form CTD PMID:29426002 acrylamide increases phosphorylation ISO RGD:736024 6480464 Acrylamide results in increased phosphorylation of MAPK9 protein CTD PMID:25531190 ADP multiple interactions ISO RGD:736023 6480464 Dicumarol inhibits the reaction [Adenosine Diphosphate results in increased phosphorylation of MAPK9 protein] CTD PMID:24466103 afimoxifene decreases response to substance ISO RGD:736023 6480464 MAPK9 results in decreased susceptibility to afimoxifene CTD PMID:21233418 aflatoxin B1 increases methylation ISO RGD:736023 6480464 Aflatoxin B1 results in increased methylation of MAPK9 intron CTD PMID:30157460 aflatoxin B1 decreases methylation ISO RGD:736023 6480464 Aflatoxin B1 results in decreased methylation of MAPK9 polyA tail CTD PMID:30157460 Aflatoxin B2 alpha decreases methylation ISO RGD:736023 6480464 aflatoxin B2 results in decreased methylation of MAPK9 polyA tail CTD PMID:30157460 aldehydo-D-glucose increases phosphorylation EXP 6480464 Glucose results in increased phosphorylation of MAPK9 protein CTD PMID:19861503 all-trans-retinoic acid multiple interactions EXP 6480464 Tretinoin results in decreased phosphorylation of and results in decreased activity of MAPK9 protein CTD PMID:16043492 all-trans-retinoic acid decreases expression ISO RGD:736024 6480464 Tretinoin results in decreased expression of MAPK9 mRNA CTD PMID:22498432 alpha-Chaconine multiple interactions ISO RGD:736024 6480464 alpha-chaconine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK9 protein] CTD PMID:25913072 alpha-mangostin increases phosphorylation ISO RGD:736023 6480464 mangostin analog results in increased phosphorylation of MAPK9 protein CTD PMID:28722351 amidotrizoic acid increases phosphorylation ISO RGD:736023 6480464 Diatrizoate results in increased phosphorylation of MAPK9 protein CTD PMID:21036957 amiloride multiple interactions ISO RGD:736024 6480464 Amiloride inhibits the reaction [azaspiracid results in increased phosphorylation of and affects the localization of MAPK9 protein] CTD PMID:19815690 amino acid multiple interactions ISO RGD:736024 6480464 Amino Acids inhibits the reaction [KL gene mutant form results in increased phosphorylation of MAPK9 protein], H 1356 inhibits the reaction [Amino Acids inhibits the reaction [KL gene mutant form results in increased phosphorylation of MAPK9 protein]] CTD PMID:25309793 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MAPK9 mRNA CTD PMID:16483693 ammonium chloride multiple interactions EXP 6480464 TLR5 gene mutant form inhibits the reaction [Ammonium Chloride results in increased phosphorylation of MAPK9 protein] CTD PMID:30508503 ammonium chloride increases phosphorylation EXP 6480464 Ammonium Chloride results in increased phosphorylation of MAPK9 protein CTD PMID:30508503 aniline increases phosphorylation EXP 6480464 aniline results in increased phosphorylation of MAPK9 protein CTD PMID:16169568 , PMID:18420242 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:16687388 more ... anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:736024 6480464 pyrazolanthrone inhibits the reaction [Acrylamide results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:18840457 more ... anthra[1,9-cd]pyrazol-6(2H)-one decreases activity ISO RGD:736023 6480464 pyrazolanthrone results in decreased activity of MAPK9 protein CTD PMID:12534346 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:736023 6480464 pyrazolanthrone inhibits the reaction [5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:15322261 more ... anthra[1,9-cd]pyrazol-6(2H)-one decreases phosphorylation EXP 6480464 pyrazolanthrone results in decreased phosphorylation of MAPK9 protein CTD PMID:22085843 ANTIMYCIN decreases phosphorylation ISO RGD:736024 6480464 antimycin results in decreased phosphorylation of MAPK9 protein CTD PMID:33290831 antirheumatic drug increases expression ISO RGD:736023 6480464 Antirheumatic Agents results in increased expression of MAPK9 mRNA CTD PMID:24449571 apigenin multiple interactions EXP 6480464 Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] CTD PMID:25557508 apocynin multiple interactions ISO RGD:736023 6480464 acetovanillone inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:21391979 more ... aristolochic acid decreases expression ISO RGD:736023 6480464 aristolochic acid I results in decreased expression of MAPK9 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:736024 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of MAPK9 mRNA CTD PMID:23650126 arsane multiple interactions EXP 6480464 Arsenic results in decreased phosphorylation of and results in decreased activity of MAPK9 protein more ... CTD PMID:11756236 , PMID:15210857 arsane multiple interactions ISO RGD:736023 6480464 Arsenic results in increased phosphorylation of and results in increased activity of MAPK9 protein CTD PMID:14633691 arsenic atom multiple interactions EXP 6480464 Arsenic results in decreased phosphorylation of and results in decreased activity of MAPK9 protein more ... CTD PMID:11756236 , PMID:15210857 arsenic atom multiple interactions ISO RGD:736023 6480464 Arsenic results in increased phosphorylation of and results in increased activity of MAPK9 protein CTD PMID:14633691 arsenic trichloride multiple interactions ISO RGD:736024 6480464 MAPK9 gene mutant form inhibits the reaction [arsenic trichloride results in increased phosphorylation of AKT1 protein], MAPK9 gene mutant form inhibits the reaction [arsenic trichloride results in increased phosphorylation of STAT3 protein] CTD PMID:22696236 arsenic trichloride increases phosphorylation ISO RGD:736023 6480464 arsenic trichloride results in increased phosphorylation of MAPK9 protein CTD PMID:22696236 , PMID:24434654 arsenic trichloride multiple interactions ISO RGD:736023 6480464 MAPK9 mutant form inhibits the reaction [arsenic trichloride results in increased expression of RIOX2 protein] more ... CTD PMID:22696236 , PMID:24434654 arsenite(3-) increases phosphorylation ISO RGD:736024 6480464 arsenite results in increased phosphorylation of MAPK9 protein CTD PMID:19808956 arsenite(3-) multiple interactions ISO RGD:736023 6480464 [[[arsenite results in increased activity of PRKDC protein] which results in increased phosphorylation of and results in increased activity of MAPK9 protein] promotes the reaction [MAPK9 protein binds to TP53 protein]] inhibits the reaction [MDM2 results in increased degradation of and results in decreased stability of TP53 protein] more ... CTD PMID:22366412 arsenite(3-) multiple interactions ISO RGD:736024 6480464 MAP3K8 protein affects the reaction [arsenite results in increased phosphorylation of MAPK9 protein] CTD PMID:19808956 arsenous acid increases phosphorylation ISO RGD:736024 6480464 Arsenic Trioxide results in increased phosphorylation of MAPK9 protein CTD PMID:15688020 arsenous acid increases activity ISO RGD:736023 6480464 Arsenic Trioxide results in increased activity of MAPK9 protein CTD PMID:12296996 arsenous acid increases phosphorylation EXP 6480464 Arsenic Trioxide results in increased phosphorylation of MAPK9 protein CTD PMID:21145380 , PMID:27174766 arsenous acid increases response to substance ISO RGD:736024 6480464 MAPK9 protein results in increased susceptibility to Arsenic Trioxide, MAPK9 results in increased susceptibility to Arsenic Trioxide CTD PMID:16818652 arsenous acid increases response to substance ISO RGD:736023 6480464 MAPK9 results in increased susceptibility to Arsenic Trioxide CTD PMID:20799280 arsenous acid increases phosphorylation ISO RGD:736023 6480464 Arsenic Trioxide results in increased phosphorylation of MAPK9 protein CTD PMID:18412143 , PMID:24466103 arsenous acid increases expression ISO RGD:736023 6480464 Arsenic Trioxide results in increased expression of MAPK9 protein CTD PMID:17374990 arsenous acid multiple interactions ISO RGD:736023 6480464 [Bortezomib co-treated with Arsenic Trioxide] affects the expression of MAPK9 protein more ... CTD PMID:15580305 more ... arsenous acid multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK9 protein], pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK9 protein] CTD PMID:21145380 , PMID:27174766 Azaspiracid multiple interactions ISO RGD:736024 6480464 4 more ... CTD PMID:19815690 benzene multiple interactions ISO RGD:736024 6480464 TRP53 protein inhibits the reaction [Benzene results in increased expression of MAPK9] CTD PMID:15935813 benzo[a]pyrene increases expression ISO RGD:736024 6480464 Benzo(a)pyrene results in increased expression of MAPK9 mRNA CTD PMID:19770486 , PMID:21715664 benzo[a]pyrene increases methylation ISO RGD:736023 6480464 Benzo(a)pyrene results in increased methylation of MAPK9 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:736024 6480464 Curcumin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK9 protein] CTD PMID:18321868 benzo[a]pyrene increases phosphorylation ISO RGD:736024 6480464 Benzo(a)pyrene results in increased phosphorylation of MAPK9 protein CTD PMID:18321868 benzo[a]pyrene diol epoxide I increases phosphorylation ISO RGD:736023 6480464 7 more ... CTD PMID:20382639 beta-hexachlorocyclohexane multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [beta-hexachlorocyclohexane results in increased phosphorylation of MAPK9 protein] CTD PMID:19760616 beta-hexachlorocyclohexane increases phosphorylation EXP 6480464 beta-hexachlorocyclohexane results in increased phosphorylation of MAPK9 protein CTD PMID:19760616 bis(2-chloroethyl) sulfide increases phosphorylation ISO RGD:736024 6480464 Mustard Gas results in increased phosphorylation of MAPK9 protein CTD PMID:18200059 bisphenol A increases phosphorylation EXP 6480464 bisphenol A results in increased phosphorylation of MAPK9 protein CTD PMID:20096755 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of MAPK9 mRNA CTD PMID:26496021 Bisphenol A diglycidyl ether multiple interactions EXP 6480464 2, 2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased phosphorylation of MAPK9 protein]] CTD PMID:27274199 bortezomib increases phosphorylation ISO RGD:736023 6480464 Bortezomib results in increased phosphorylation of MAPK9 protein CTD PMID:18559525 bortezomib multiple interactions ISO RGD:736023 6480464 [Bortezomib co-treated with arsenic trioxide] affects the expression of MAPK9 protein more ... CTD PMID:16985072 more ... bufalin decreases activity ISO RGD:736023 6480464 bufalin results in decreased activity of MAPK9 protein CTD PMID:21922632 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of MAPK9 mRNA CTD PMID:24136188 cadmium atom multiple interactions ISO RGD:736024 6480464 1 more ... CTD PMID:15254339 more ... cadmium atom increases phosphorylation ISO RGD:736023 6480464 Cadmium results in increased phosphorylation of MAPK9 protein CTD PMID:26187450 , PMID:26514923 cadmium atom multiple interactions ISO RGD:736023 6480464 acetovanillone inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:26187450 , PMID:26514923 cadmium atom affects response to substance ISO RGD:736023 6480464 MAPK9 affects the susceptibility to Cadmium CTD PMID:10874022 cadmium atom affects response to substance EXP 6480464 MAPK9 protein affects the susceptibility to Cadmium CTD PMID:16516943 cadmium atom multiple interactions EXP 6480464 Cadmium results in increased phosphorylation of and results in increased activity of MAPK9 protein CTD PMID:16568437 cadmium atom increases phosphorylation ISO RGD:736024 6480464 Cadmium results in increased phosphorylation of MAPK9 protein CTD PMID:15212812 , PMID:15254339 cadmium dichloride multiple interactions ISO RGD:736024 6480464 1 more ... CTD PMID:11958953 more ... cadmium dichloride increases expression ISO RGD:736023 6480464 Cadmium Chloride results in increased expression of MAPK9 protein modified form CTD PMID:24419708 cadmium dichloride increases phosphorylation EXP 6480464 Cadmium Chloride results in increased phosphorylation of MAPK9 protein CTD PMID:23876460 , PMID:31348969 cadmium dichloride increases phosphorylation ISO RGD:736024 6480464 Cadmium Chloride results in increased phosphorylation of MAPK9 protein CTD PMID:11958953 cadmium dichloride increases phosphorylation ISO RGD:736023 6480464 Cadmium Chloride results in increased phosphorylation of MAPK9 protein CTD PMID:10874044 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of MAPK9 promoter CTD PMID:22457795 cadmium dichloride multiple interactions EXP 6480464 1 more ... CTD PMID:15618353 more ... cadmium dichloride multiple interactions ISO RGD:736023 6480464 1 more ... CTD PMID:12634122 , PMID:21544200 cadmium sulfate multiple interactions ISO RGD:736024 6480464 Acetylcysteine inhibits the reaction [cadmium sulfate results in increased phosphorylation of and results in increased activity of MAPK9 protein], cadmium sulfate results in increased phosphorylation of and results in increased activity of MAPK9 protein CTD PMID:14687664 cadmium sulfate increases phosphorylation EXP 6480464 cadmium sulfate results in increased phosphorylation of MAPK9 protein CTD PMID:22767315 cadmium sulfate multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [cadmium sulfate results in increased phosphorylation of MAPK9 protein], Glutathione inhibits the reaction [cadmium sulfate results in increased phosphorylation of MAPK9 protein] CTD PMID:22767315 calcidiol decreases expression EXP 6480464 Calcifediol deficiency results in decreased expression of MAPK9 mRNA CTD PMID:17293106 calix[6]arene increases phosphorylation ISO RGD:736023 6480464 calix(6)arene results in increased phosphorylation of MAPK9 protein CTD PMID:23872419 camptothecin increases phosphorylation ISO RGD:736023 6480464 Camptothecin results in increased phosphorylation of MAPK9 protein CTD PMID:15585644 cannabidiol increases phosphorylation ISO RGD:736023 6480464 Cannabidiol results in increased phosphorylation of MAPK9 protein CTD PMID:32060308 cantharidic acid increases phosphorylation ISO RGD:736023 6480464 cantharidic acid results in increased phosphorylation of MAPK9 protein CTD PMID:29345422 capsaicin multiple interactions ISO RGD:736023 6480464 Capsaicin inhibits the reaction [EGF results in increased phosphorylation of MAPK9 protein], Capsaicin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK9 protein] CTD PMID:21462327 , PMID:21745629 capsaicin increases activity ISO RGD:736023 6480464 Capsaicin results in increased activity of MAPK9 protein CTD PMID:9580328 capsaicin increases phosphorylation ISO RGD:736023 6480464 Capsaicin results in increased phosphorylation of MAPK9 protein CTD PMID:20619260 carbon nanotube decreases expression ISO RGD:736024 6480464 Nanotubes, Carbon analog results in decreased expression of MAPK9 mRNA CTD PMID:25554681 carnosic acid multiple interactions EXP 6480464 salvin inhibits the reaction [Oxidopamine results in increased phosphorylation of MAPK9 protein] CTD PMID:25446857 chenodeoxycholic acid multiple interactions ISO RGD:736024 6480464 Chenodeoxycholic Acid inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein], Chenodeoxycholic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] CTD PMID:25496033 chenodeoxycholic acid multiple interactions ISO RGD:736023 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPK9 mRNA CTD PMID:32152650 chlorpyrifos decreases expression ISO RGD:736024 6480464 Chlorpyrifos results in decreased expression of MAPK9 mRNA CTD PMID:29156651 choline multiple interactions ISO RGD:736024 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAPK9 gene more ... CTD PMID:20938992 , PMID:23038002 chromium atom multiple interactions ISO RGD:736024 6480464 Chromium inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK9 protein] CTD PMID:21134603 chromium(6+) multiple interactions ISO RGD:736024 6480464 [Arsenates co-treated with chromium hexavalent ion] results in increased expression of MAPK9 protein more ... CTD PMID:19654923 , PMID:19895865 chromium(6+) increases phosphorylation ISO RGD:736024 6480464 chromium hexavalent ion results in increased phosphorylation of MAPK9 protein CTD PMID:19654923 , PMID:19895865 chromium(6+) increases expression ISO RGD:736024 6480464 chromium hexavalent ion results in increased expression of MAPK9 protein CTD PMID:19895865 chromium(6+) increases phosphorylation ISO RGD:736023 6480464 chromium hexavalent ion results in increased phosphorylation of MAPK9 protein CTD PMID:17045426 chromones multiple interactions ISO RGD:736023 6480464 N-(oxo-5 more ... CTD PMID:22583868 chromones increases expression ISO RGD:736023 6480464 Chromones analog results in increased expression of MAPK9 protein modified form CTD PMID:22583868 cisplatin multiple interactions ISO RGD:736023 6480464 [Cisplatin co-treated with 2 more ... CTD PMID:21214929 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of MAPK9 protein modified form CTD PMID:26739623 cisplatin multiple interactions EXP 6480464 Lovastatin inhibits the reaction [Cisplatin results in increased expression of MAPK9 protein modified form], N-Acetylcysteinamide inhibits the reaction [Cisplatin results in increased phosphorylation of MAPK9 protein] CTD PMID:15147517 , PMID:26739623 cisplatin increases phosphorylation EXP 6480464 Cisplatin results in increased phosphorylation of MAPK9 protein CTD PMID:15147517 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MAPK9 mRNA CTD PMID:17602206 clozapine affects expression EXP 6480464 Clozapine affects the expression of MAPK9 mRNA CTD PMID:15860345 cobalt dichloride increases phosphorylation EXP 6480464 cobaltous chloride results in increased phosphorylation of MAPK9 protein CTD PMID:21925238 , PMID:22669716 cobalt dichloride multiple interactions EXP 6480464 Protein Kinase Inhibitors inhibits the reaction [cobaltous chloride results in increased phosphorylation of MAPK9 protein] CTD PMID:21925238 cobalt dichloride increases phosphorylation ISO RGD:736023 6480464 cobaltous chloride results in increased phosphorylation of MAPK9 protein CTD PMID:19101624 , PMID:24386346 cobalt dichloride multiple interactions ISO RGD:736023 6480464 Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of MAPK9 protein], ginsenoside Rg1 inhibits the reaction [cobaltous chloride results in increased phosphorylation of MAPK9 protein] CTD PMID:24386346 copper atom multiple interactions EXP 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK9 protein more ... CTD PMID:22085843 copper atom multiple interactions ISO RGD:736023 6480464 [Disulfiram binds to Copper] which results in increased phosphorylation of MAPK9 protein, Copper inhibits the reaction [IAPP protein results in increased phosphorylation of MAPK9 protein] CTD PMID:23793354 , PMID:24690739 copper atom multiple interactions ISO RGD:736024 6480464 [Disulfiram binds to Copper] which results in increased phosphorylation of MAPK9 protein CTD PMID:24690739 copper(0) multiple interactions EXP 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK9 protein more ... CTD PMID:22085843 copper(0) multiple interactions ISO RGD:736023 6480464 [Disulfiram binds to Copper] which results in increased phosphorylation of MAPK9 protein, Copper inhibits the reaction [IAPP protein results in increased phosphorylation of MAPK9 protein] CTD PMID:23793354 , PMID:24690739 copper(0) multiple interactions ISO RGD:736024 6480464 [Disulfiram binds to Copper] which results in increased phosphorylation of MAPK9 protein CTD PMID:24690739 copper(II) sulfate decreases expression ISO RGD:736023 6480464 Copper Sulfate results in decreased expression of MAPK9 mRNA CTD PMID:19549813 crocidolite asbestos multiple interactions ISO RGD:736023 6480464 Asbestos, Crocidolite results in decreased expression of and results in decreased phosphorylation of MAPK9 protein CTD PMID:17191120 curcumin multiple interactions ISO RGD:736024 6480464 Curcumin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MAPK9 protein] CTD PMID:18321868 curcumin decreases phosphorylation EXP 6480464 Curcumin results in decreased phosphorylation of MAPK9 protein CTD PMID:18332871 curcumin increases phosphorylation ISO RGD:736023 6480464 Curcumin results in increased phosphorylation of MAPK9 protein CTD PMID:18316600 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [sodium arsenite results in increased expression of MAPK9 protein] more ... CTD PMID:11981161 more ... cyclophosphamide multiple interactions EXP 6480464 Cyclophosphamide results in increased phosphorylation of and results in increased activity of MAPK9 protein, NGF protein affects the reaction [Cyclophosphamide results in increased phosphorylation of and results in increased activity of MAPK9 protein] CTD PMID:19996110 cyclosporin A increases expression ISO RGD:736023 6480464 Cyclosporine results in increased expression of MAPK9 mRNA CTD PMID:20106945 , PMID:32152650 cyclosporin A multiple interactions ISO RGD:736023 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPK9 mRNA CTD PMID:32152650 cypermethrin multiple interactions ISO RGD:736024 6480464 [[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK9 protein CTD PMID:29471534 D-glucose increases phosphorylation EXP 6480464 Glucose results in increased phosphorylation of MAPK9 protein CTD PMID:19861503 DDT decreases phosphorylation ISO RGD:736023 6480464 DDT results in decreased phosphorylation of MAPK9 protein CTD PMID:14604893 deoxycholic acid multiple interactions ISO RGD:736023 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPK9 mRNA CTD PMID:32152650 Deoxycorticosterone acetate multiple interactions EXP 6480464 chromium mesoporphyrin inhibits the reaction [heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in increased expression of MAPK9 mRNA]] more ... CTD PMID:23089228 Deoxycorticosterone acetate increases expression EXP 6480464 Desoxycorticosterone Acetate results in increased expression of MAPK9 mRNA CTD PMID:23089228 deoxynivalenol multiple interactions ISO RGD:736024 6480464 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3 more ... CTD PMID:14644621 more ... deoxynivalenol increases phosphorylation ISO RGD:736023 6480464 deoxynivalenol results in increased phosphorylation of MAPK9 protein CTD PMID:20633634 deoxynivalenol multiple interactions ISO RGD:736023 6480464 [deoxynivalenol results in increased expression of DUSP1 protein] which results in decreased activity of MAPK9 protein, deoxynivalenol results in increased phosphorylation of and results in increased activity of MAPK9 protein CTD PMID:18485432 more ... deoxynivalenol decreases activity ISO RGD:736023 6480464 deoxynivalenol results in decreased activity of MAPK9 protein CTD PMID:20708668 deoxynivalenol increases phosphorylation ISO RGD:736024 6480464 deoxynivalenol results in increased phosphorylation of MAPK9 protein CTD PMID:12377986 more ... deoxynivalenol decreases phosphorylation ISO RGD:736024 6480464 deoxynivalenol results in decreased phosphorylation of MAPK9 protein CTD PMID:23352502 deoxynivalenol decreases expression ISO RGD:736024 6480464 deoxynivalenol results in decreased expression of MAPK9 mRNA CTD PMID:15371230 desferrioxamine B increases phosphorylation ISO RGD:736023 6480464 Deferoxamine results in increased phosphorylation of MAPK9 protein CTD PMID:20368581 desferrioxamine B multiple interactions ISO RGD:736023 6480464 Deferoxamine inhibits the reaction [Plant Extracts results in increased phosphorylation of MAPK9 protein] CTD PMID:20206247 dexamethasone multiple interactions ISO RGD:736024 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased phosphorylation of MAPK9 protein more ... CTD PMID:27568862 , PMID:30721698 diarsenic trioxide increases response to substance ISO RGD:736023 6480464 MAPK9 results in increased susceptibility to Arsenic Trioxide CTD PMID:20799280 diarsenic trioxide increases response to substance ISO RGD:736024 6480464 MAPK9 protein results in increased susceptibility to Arsenic Trioxide, MAPK9 results in increased susceptibility to Arsenic Trioxide CTD PMID:16818652 diarsenic trioxide increases phosphorylation EXP 6480464 Arsenic Trioxide results in increased phosphorylation of MAPK9 protein CTD PMID:21145380 , PMID:27174766 diarsenic trioxide multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK9 protein], pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of MAPK9 protein] CTD PMID:21145380 , PMID:27174766 diarsenic trioxide increases activity ISO RGD:736023 6480464 Arsenic Trioxide results in increased activity of MAPK9 protein CTD PMID:12296996 diarsenic trioxide multiple interactions ISO RGD:736023 6480464 [Bortezomib co-treated with Arsenic Trioxide] affects the expression of MAPK9 protein more ... CTD PMID:15580305 more ... diarsenic trioxide increases phosphorylation ISO RGD:736023 6480464 Arsenic Trioxide results in increased phosphorylation of MAPK9 protein CTD PMID:18412143 , PMID:24466103 diarsenic trioxide increases expression ISO RGD:736023 6480464 Arsenic Trioxide results in increased expression of MAPK9 protein CTD PMID:17374990 diarsenic trioxide increases phosphorylation ISO RGD:736024 6480464 Arsenic Trioxide results in increased phosphorylation of MAPK9 protein CTD PMID:15688020 dibenziodolium multiple interactions ISO RGD:736023 6480464 diphenyleneiodonium inhibits the reaction [[Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:21391979 more ... dichromium trioxide multiple interactions ISO RGD:736023 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAPK9 mRNA CTD PMID:12634122 dicoumarol multiple interactions ISO RGD:736023 6480464 Dicumarol inhibits the reaction [Adenosine Diphosphate results in increased phosphorylation of MAPK9 protein] CTD PMID:24466103 dioscin increases expression ISO RGD:736023 6480464 dioscin results in increased expression of MAPK9 mRNA CTD PMID:29990575 dioxygen multiple interactions ISO RGD:736023 6480464 MAPK9 protein affects the reaction [Oxygen deficiency results in increased expression of BACE1 protein], TXN protein promotes the reaction [Oxygen results in increased phosphorylation of MAPK9 protein] CTD PMID:19196431 , PMID:20812253 dioxygen multiple interactions EXP 6480464 2 more ... CTD PMID:27274199 dioxygen increases phosphorylation EXP 6480464 Oxygen results in increased phosphorylation of MAPK9 protein CTD PMID:20812253 dioxygen increases phosphorylation ISO RGD:736023 6480464 Oxygen deficiency results in increased phosphorylation of MAPK9 protein CTD PMID:19196431 diquat multiple interactions ISO RGD:736024 6480464 PROP1 protein affects the reaction [Diquat affects the phosphorylation of MAPK9 protein] CTD PMID:20826540 disodium selenite multiple interactions ISO RGD:736023 6480464 pyrazolanthrone inhibits the reaction [Sodium Selenite results in increased phosphorylation of and results in increased activity of MAPK9 protein], Sodium Selenite results in increased phosphorylation of and results in increased activity of MAPK9 protein CTD PMID:18728404 disodium selenite multiple interactions ISO RGD:736024 6480464 Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAPK9 protein] CTD PMID:26522834 disodium selenite affects expression EXP 6480464 Sodium Selenite affects the expression of MAPK9 CTD PMID:18209489 disodium selenite increases expression ISO RGD:736023 6480464 Sodium Selenite results in increased expression of MAPK9 protein CTD PMID:18728404 disulfiram multiple interactions ISO RGD:736024 6480464 [Disulfiram binds to Copper] which results in increased phosphorylation of MAPK9 protein CTD PMID:24690739 disulfiram multiple interactions ISO RGD:736023 6480464 [Disulfiram binds to Copper] which results in increased phosphorylation of MAPK9 protein CTD PMID:24690739 dobutamine multiple interactions EXP 6480464 [Dobutamine co-treated with ICI 118551] results in increased activity of MAPK9 protein CTD PMID:19719783 donepezil hydrochloride multiple interactions EXP 6480464 Donepezil inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of MAPK9 protein] CTD PMID:19345205 dorsomorphin multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [Resveratrol results in decreased expression of MAPK9 protein modified form] CTD PMID:27093858 doxorubicin multiple interactions ISO RGD:736023 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:15494689 more ... doxorubicin decreases expression ISO RGD:736023 6480464 Doxorubicin results in decreased expression of MAPK9 mRNA CTD PMID:29803840 doxorubicin increases phosphorylation EXP 6480464 Doxorubicin results in increased phosphorylation of MAPK9 protein CTD PMID:16213474 more ... doxorubicin multiple interactions EXP 6480464 [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:16687611 , PMID:26335259 doxorubicin increases phosphorylation ISO RGD:736023 6480464 Doxorubicin results in increased phosphorylation of MAPK9 protein CTD PMID:15557793 more ... ebselen increases phosphorylation EXP 6480464 ebselen results in increased phosphorylation of MAPK9 protein CTD PMID:27282967 elemental selenium multiple interactions ISO RGD:736023 6480464 Selenium inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein] CTD PMID:26187450 ellagic acid multiple interactions ISO RGD:736023 6480464 [Ellagic Acid co-treated with Quercetin] results in increased phosphorylation of MAPK9 protein CTD PMID:15735102 emetine multiple interactions ISO RGD:736024 6480464 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3, 4-d)pyrimidine inhibits the reaction [Emetine results in increased phosphorylation of MAPK9 protein] CTD PMID:15772366 emetine increases phosphorylation ISO RGD:736024 6480464 Emetine results in increased phosphorylation of MAPK9 protein CTD PMID:15772366 enalapril increases expression EXP 6480464 Enalapril results in increased expression of MAPK9 mRNA, Enalapril results in increased expression of MAPK9 protein CTD PMID:15531746 enalapril increases phosphorylation EXP 6480464 Enalapril results in increased phosphorylation of MAPK9 protein CTD PMID:15531746 enzyme inhibitor multiple interactions ISO RGD:736023 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MAPK9 protein CTD PMID:23301498 esculetin multiple interactions ISO RGD:736023 6480464 [esculetin co-treated with Paclitaxel] results in increased expression of MAPK9 protein CTD PMID:16051289 esculetin increases expression ISO RGD:736023 6480464 esculetin results in increased expression of MAPK9 protein CTD PMID:16051289 Estragole increases phosphorylation EXP 6480464 estragole results in increased phosphorylation of MAPK9 protein CTD PMID:29054680 ethanol affects expression EXP 6480464 Ethanol affects the expression of MAPK9 mRNA CTD PMID:11772933 ethanol affects splicing ISO RGD:736024 6480464 Ethanol affects the splicing of MAPK9 mRNA CTD PMID:30319688 ethanol increases phosphorylation ISO RGD:736023 6480464 Ethanol results in increased phosphorylation of MAPK9 protein CTD PMID:28062356 ethanol increases phosphorylation ISO RGD:736024 6480464 Ethanol results in increased phosphorylation of MAPK9 protein CTD PMID:28119953 Ethyl pyruvate multiple interactions EXP 6480464 ethyl pyruvate inhibits the reaction [Phosgene results in increased phosphorylation of MAPK9 protein] CTD PMID:21818760 ethylene glycol bis(2-aminoethyl)tetraacetic acid multiple interactions EXP 6480464 Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein], Egtazic Acid inhibits the reaction [Tetracaine results in increased phosphorylation of MAPK9 protein] CTD PMID:11981161 , PMID:21544200 ethylene glycol bis(2-aminoethyl)tetraacetic acid multiple interactions ISO RGD:736024 6480464 Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein], Egtazic Acid inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein] CTD PMID:15254339 , PMID:21544200 ethylene glycol bis(2-aminoethyl)tetraacetic acid multiple interactions ISO RGD:736023 6480464 Egtazic Acid inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] CTD PMID:21544200 Evodiamine multiple interactions ISO RGD:736023 6480464 1 more ... CTD PMID:23774672 Evodiamine increases expression ISO RGD:736023 6480464 evodiamine results in increased expression of MAPK9 protein modified form CTD PMID:23774672 ferrosoferric oxide multiple interactions ISO RGD:736023 6480464 [Ferrosoferric Oxide binds to titanium dioxide] which results in increased phosphorylation of MAPK9 protein CTD PMID:30098274 fluorescein 5-isothiocyanate multiple interactions ISO RGD:736023 6480464 Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK9 protein], Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] CTD PMID:27129696 fluorescein 5-isothiocyanate increases phosphorylation ISO RGD:736023 6480464 Fluorescein-5-isothiocyanate results in increased phosphorylation of MAPK9 protein CTD PMID:27129696 folic acid multiple interactions ISO RGD:736024 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAPK9 gene CTD PMID:20938992 fomepizole affects binding ISO RGD:736024 6480464 Fomepizole binds to MAPK9 protein CTD PMID:30903181 formaldehyde decreases expression ISO RGD:736023 6480464 Formaldehyde results in decreased expression of MAPK9 mRNA CTD PMID:23649840 formoterol fumarate multiple interactions EXP 6480464 Formoterol Fumarate inhibits the reaction [dinitrophenyl-bovine serum albumin results in increased phosphorylation of MAPK9 protein] CTD PMID:26003274 gallic acid multiple interactions ISO RGD:736023 6480464 Gallic Acid inhibits the reaction [TNF protein results in increased phosphorylation of MAPK9 protein] CTD PMID:21420233 gamma-hexachlorocyclohexane multiple interactions EXP 6480464 Hexachlorocyclohexane results in increased phosphorylation of and results in increased activity of MAPK9 protein CTD PMID:23927878 Geniposide pentaacetate multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [pentaacetyl geniposide results in increased phosphorylation of MAPK9 protein] CTD PMID:17651887 Geniposide pentaacetate increases phosphorylation EXP 6480464 pentaacetyl geniposide results in increased phosphorylation of MAPK9 protein CTD PMID:17651887 ginsenoside Rg1 multiple interactions ISO RGD:736023 6480464 ginsenoside Rg1 inhibits the reaction [cobaltous chloride results in increased phosphorylation of MAPK9 protein] CTD PMID:24386346 glucose increases phosphorylation EXP 6480464 Glucose results in increased phosphorylation of MAPK9 protein CTD PMID:19861503 glutathione multiple interactions ISO RGD:736024 6480464 Glutathione inhibits the reaction [Acetaminophen results in increased phosphorylation of MAPK9 protein] CTD PMID:20423716 glutathione multiple interactions EXP 6480464 Glutathione inhibits the reaction [cadmium sulfate results in increased phosphorylation of MAPK9 protein] CTD PMID:22767315 glycochenodeoxycholic acid multiple interactions ISO RGD:736023 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPK9 mRNA CTD PMID:32152650 glycocholic acid multiple interactions ISO RGD:736023 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPK9 mRNA CTD PMID:32152650 glycodeoxycholic acid multiple interactions ISO RGD:736023 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPK9 mRNA CTD PMID:32152650 GW 4064 multiple interactions ISO RGD:736023 6480464 GW 4064 inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:25496033 GW 4064 multiple interactions ISO RGD:736024 6480464 GW 4064 inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein], GW 4064 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] CTD PMID:25496033 haloperidol affects expression EXP 6480464 Haloperidol affects the expression of MAPK9 mRNA CTD PMID:15860345 hemin multiple interactions EXP 6480464 chromium mesoporphyrin inhibits the reaction [Hemin inhibits the reaction [Streptozocin results in increased expression of MAPK9 mRNA]], Hemin inhibits the reaction [Streptozocin results in increased expression of MAPK9 mRNA] CTD PMID:19190261 hemin decreases expression EXP 6480464 Hemin results in decreased expression of MAPK9 mRNA CTD PMID:20016031 hesperidin multiple interactions ISO RGD:736023 6480464 Hesperidin inhibits the reaction [Acetaldehyde results in increased phosphorylation of MAPK9 protein] CTD PMID:19110045 hexadecanoic acid multiple interactions ISO RGD:736023 6480464 Capsaicin inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK9 protein] CTD PMID:21745629 hexadecanoic acid multiple interactions EXP 6480464 4-hydroxyisoleucine inhibits the reaction [Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK9 protein]], Palmitic Acid inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of MAPK9 protein] CTD PMID:25109277 hexadecanoic acid increases phosphorylation ISO RGD:736024 6480464 Palmitic Acid results in increased phosphorylation of MAPK9 protein CTD PMID:21134603 hexadecanoic acid multiple interactions ISO RGD:736024 6480464 Chromium inhibits the reaction [Palmitic Acid results in increased phosphorylation of MAPK9 protein] CTD PMID:21134603 hexadecanoic acid increases phosphorylation ISO RGD:736023 6480464 Palmitic Acid results in increased phosphorylation of MAPK9 protein CTD PMID:21745629 hexamethylene diisocyanate multiple interactions ISO RGD:736023 6480464 1, 6-hexamethylene diisocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] CTD PMID:27129696 hexamethylene diisocyanate increases phosphorylation ISO RGD:736023 6480464 1, 6-hexamethylene diisocyanate results in increased phosphorylation of MAPK9 protein CTD PMID:27129696 homocysteine increases phosphorylation ISO RGD:736023 6480464 Homocysteine results in increased phosphorylation of MAPK9 protein CTD PMID:25888188 homocysteine multiple interactions ISO RGD:736023 6480464 fulvic acid inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK9 protein] CTD PMID:25888188 hydrogen peroxide decreases expression ISO RGD:736023 6480464 Hydrogen Peroxide results in decreased expression of MAPK9 mRNA CTD PMID:12419474 hydrogen peroxide increases phosphorylation EXP 6480464 Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein CTD PMID:16362428 more ... hydrogen peroxide increases phosphorylation ISO RGD:736024 6480464 Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein CTD PMID:25496033 , PMID:33290831 hydrogen peroxide multiple interactions ISO RGD:736024 6480464 Chenodeoxycholic Acid inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein], GW 4064 inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein] CTD PMID:25496033 hydrogen peroxide increases phosphorylation ISO RGD:736023 6480464 Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein CTD PMID:15795422 more ... hydrogen peroxide increases activity ISO RGD:736024 6480464 Hydrogen Peroxide results in increased activity of MAPK9 protein CTD PMID:11181820 , PMID:14975446 hydrogen peroxide increases activity EXP 6480464 Hydrogen Peroxide results in increased activity of MAPK9 protein CTD PMID:15574683 hydrogen peroxide multiple interactions EXP 6480464 2-(4-((dimethylamino)methyl)benzylidene)-5 more ... CTD PMID:15574683 more ... hydrogen peroxide multiple interactions ISO RGD:736023 6480464 2''-galloylhyperin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:15795422 more ... hydrogen sulfide increases phosphorylation ISO RGD:736024 6480464 Hydrogen Sulfide results in increased phosphorylation of MAPK9 protein CTD PMID:31843631 hypochlorous acid multiple interactions ISO RGD:736023 6480464 Hypochlorous Acid results in increased phosphorylation of and results in increased activity of MAPK9 protein CTD PMID:18156441 ICI 118551 multiple interactions EXP 6480464 [Dobutamine co-treated with ICI 118551] results in increased activity of MAPK9 protein CTD PMID:19719783 indoxyl sulfate increases phosphorylation EXP 6480464 Indican results in increased phosphorylation of MAPK9 protein CTD PMID:32045570 iomeprol increases phosphorylation ISO RGD:736023 6480464 iomeprol results in increased phosphorylation of MAPK9 protein CTD PMID:21036957 kaempferol increases phosphorylation ISO RGD:736023 6480464 kaempferol results in increased phosphorylation of MAPK9 protein CTD PMID:30499162 L-ascorbic acid multiple interactions ISO RGD:736023 6480464 [Ascorbic Acid co-treated with Eosine I Bluish] results in increased phosphorylation of MAPK9 protein more ... CTD PMID:20206247 , PMID:24488945 L-cysteine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Cysteine deficiency] results in increased activity of MAPK9 protein CTD PMID:11709198 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Cysteine deficiency] results in increased activity of MAPK9 protein CTD PMID:11709198 L-methionine multiple interactions ISO RGD:736024 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MAPK9 gene more ... CTD PMID:20938992 , PMID:23038002 lead diacetate multiple interactions ISO RGD:736023 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAPK9 mRNA CTD PMID:12634122 lead diacetate increases phosphorylation EXP 6480464 lead acetate results in increased phosphorylation of MAPK9 protein CTD PMID:25088297 lead diacetate multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Cadmium Chloride co-treated with sodium arsenite co-treated with lead acetate] results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:20829427 , PMID:25088297 lead(0) affects expression ISO RGD:736023 6480464 Lead affects the expression of MAPK9 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:736023 6480464 Lead affects the expression of MAPK9 mRNA CTD PMID:28903495 lead(II) chloride increases expression ISO RGD:736023 6480464 lead chloride results in increased expression of MAPK9 protein modified form CTD PMID:24419708 Licochalcone A multiple interactions ISO RGD:736023 6480464 licochalcone A promotes the reaction [Sorafenib results in decreased phosphorylation of MAPK9 protein], Sorafenib promotes the reaction [licochalcone A results in decreased phosphorylation of MAPK9 protein] CTD PMID:30187994 Licochalcone A decreases phosphorylation ISO RGD:736023 6480464 licochalcone A results in decreased phosphorylation of MAPK9 protein CTD PMID:30187994 Licochalcone B multiple interactions ISO RGD:736024 6480464 licochalcone B analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] CTD PMID:25451593 lipopolysaccharide increases phosphorylation ISO RGD:736024 6480464 Lipopolysaccharides results in increased phosphorylation of MAPK9 protein CTD PMID:14644621 more ... lipopolysaccharide increases phosphorylation EXP 6480464 Lipopolysaccharides results in increased phosphorylation of MAPK9 protein CTD PMID:25557508 lipopolysaccharide multiple interactions EXP 6480464 Apigenin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] CTD PMID:25557508 lipopolysaccharide increases expression ISO RGD:736024 6480464 Lipopolysaccharides results in increased expression of MAPK9 protein modified form CTD PMID:15832817 lipopolysaccharide multiple interactions ISO RGD:736024 6480464 2'-hydroxyflavanone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:14644621 more ... lipopolysaccharide increases phosphorylation ISO RGD:736023 6480464 Lipopolysaccharides results in increased phosphorylation of MAPK9 protein CTD PMID:21911040 more ... lipopolysaccharide multiple interactions ISO RGD:736023 6480464 1 more ... CTD PMID:21391979 more ... lithium atom increases expression EXP 6480464 Lithium results in increased expression of MAPK9 protein CTD PMID:18296634 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of MAPK9 protein CTD PMID:18296634 Longikaurin A multiple interactions ISO RGD:736023 6480464 Acetylcysteine inhibits the reaction [longikaurin A results in increased phosphorylation of MAPK9 protein] CTD PMID:28801140 Longikaurin A increases phosphorylation ISO RGD:736023 6480464 longikaurin A results in increased phosphorylation of MAPK9 protein CTD PMID:28801140 lovastatin multiple interactions EXP 6480464 Lovastatin inhibits the reaction [Cisplatin results in increased expression of MAPK9 protein modified form] CTD PMID:26739623 luteolin increases phosphorylation ISO RGD:736023 6480464 Luteolin results in increased phosphorylation of MAPK9 protein CTD PMID:21601631 luteolin multiple interactions ISO RGD:736023 6480464 Luteolin analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] CTD PMID:30133131 LY294002 increases phosphorylation ISO RGD:736023 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased phosphorylation of MAPK9 protein CTD PMID:14688022 LY294002 multiple interactions ISO RGD:736023 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tricarbonyldichlororuthenium (II) dimer results in increased phosphorylation of MAPK9 protein] CTD PMID:26385185 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased phosphorylation of and results in increased activity of MAPK9 protein CTD PMID:16018989 Magnolol multiple interactions ISO RGD:736024 6480464 magnolol inhibits the reaction [trimethyltin results in increased phosphorylation of MAPK9 protein] CTD PMID:26756313 Malonoben multiple interactions ISO RGD:736023 6480464 tyrphostin A9 inhibits the reaction [S100A4 protein results in increased phosphorylation of MAPK9 protein] CTD PMID:16948116 manganese atom increases phosphorylation ISO RGD:736023 6480464 Manganese results in increased phosphorylation of MAPK9 protein CTD PMID:17045426 , PMID:22561169 manganese atom multiple interactions ISO RGD:736023 6480464 Manganese promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] CTD PMID:22561169 manganese(0) increases phosphorylation ISO RGD:736023 6480464 Manganese results in increased phosphorylation of MAPK9 protein CTD PMID:17045426 , PMID:22561169 manganese(0) multiple interactions ISO RGD:736023 6480464 Manganese promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] CTD PMID:22561169 manganese(II) chloride increases activity ISO RGD:736023 6480464 manganese chloride results in increased activity of MAPK9 protein CTD PMID:20152896 manganese(II) chloride increases phosphorylation ISO RGD:736023 6480464 manganese chloride results in increased phosphorylation of MAPK9 protein CTD PMID:19084589 , PMID:20152896 mangiferin decreases expression ISO RGD:736024 6480464 mangiferin results in decreased expression of MAPK9 mRNA CTD PMID:15135318 manumycin A multiple interactions ISO RGD:736024 6480464 manumycin inhibits the reaction [Acetaminophen results in increased phosphorylation of and results in increased activity of MAPK9 protein] CTD PMID:19739265 masoprocol multiple interactions ISO RGD:736023 6480464 Masoprocol inhibits the reaction [FN1 protein modified form results in increased expression of MAPK9 protein modified form] CTD PMID:17395008 mebendazole increases phosphorylation ISO RGD:736023 6480464 Mebendazole results in increased phosphorylation of MAPK9 protein CTD PMID:20848085 mechlorethamine increases phosphorylation ISO RGD:736024 6480464 Mechlorethamine results in increased phosphorylation of MAPK9 protein CTD PMID:25891025 melatonin increases expression ISO RGD:736023 6480464 Melatonin results in increased expression of MAPK9 protein CTD PMID:19012662 mercury dichloride increases phosphorylation ISO RGD:736024 6480464 Mercuric Chloride results in increased phosphorylation of MAPK9 protein CTD PMID:10861847 metformin multiple interactions ISO RGD:736023 6480464 Metformin inhibits the reaction [IL1B protein results in increased phosphorylation of MAPK9 protein] CTD PMID:16385087 methamphetamine increases phosphorylation ISO RGD:736024 6480464 Methamphetamine results in increased phosphorylation of MAPK9 protein CTD PMID:32768653 methotrexate increases phosphorylation EXP 6480464 Methotrexate results in increased phosphorylation of MAPK9 protein CTD PMID:20885979 methotrexate increases expression ISO RGD:736023 6480464 Methotrexate results in increased expression of MAPK9 mRNA CTD PMID:22183962 methotrexate multiple interactions ISO RGD:736023 6480464 MAPK9 gene mutant form inhibits the reaction [Methotrexate results in increased expression of TP53 protein] CTD PMID:22183962 Methylazoxymethanol acetate increases expression EXP 6480464 Methylazoxymethanol Acetate results in increased expression of MAPK9 mRNA CTD PMID:28349193 methylglyoxal increases phosphorylation ISO RGD:736023 6480464 Pyruvaldehyde results in increased phosphorylation of MAPK9 protein CTD PMID:25933243 methylglyoxal multiple interactions ISO RGD:736023 6480464 sulforaphane inhibits the reaction [Pyruvaldehyde results in increased phosphorylation of MAPK9 protein] CTD PMID:25933243 methylmercury chloride increases phosphorylation ISO RGD:736024 6480464 methylmercuric chloride results in increased phosphorylation of MAPK9 protein CTD PMID:27667695 methylseleninic acid decreases expression ISO RGD:736023 6480464 methylselenic acid results in decreased expression of MAPK9 mRNA CTD PMID:11830524 microcystin-LR increases expression ISO RGD:736024 6480464 cyanoginosin LR results in increased expression of MAPK9 mRNA CTD PMID:17654400 microcystin-LR multiple interactions ISO RGD:736023 6480464 [IGBP1 protein results in increased susceptibility to cyanoginosin LR] which results in increased phosphorylation of MAPK9 protein CTD PMID:29984889 mycophenolic acid multiple interactions ISO RGD:736023 6480464 Mycophenolic Acid inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein] CTD PMID:20302854 mycophenolic acid decreases expression EXP 6480464 Mycophenolic Acid results in decreased expression of MAPK9 protein modified form CTD PMID:20302854 myricetin multiple interactions ISO RGD:736024 6480464 myricetin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK9 protein], myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] CTD PMID:17693661 N(6),N(6)-dimethyladenine multiple interactions EXP 6480464 N(6), N(6)-dimethyladenine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] CTD PMID:15618353 N-acetyl-L-cysteine multiple interactions ISO RGD:736024 6480464 Acetylcysteine inhibits the reaction [1 more ... CTD PMID:14687664 more ... N-acetyl-L-cysteine decreases phosphorylation ISO RGD:736023 6480464 Acetylcysteine results in decreased phosphorylation of MAPK9 protein CTD PMID:24735948 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:19760616 more ... N-acetyl-L-cysteine multiple interactions ISO RGD:736023 6480464 Acetylcysteine inhibits the reaction [2 more ... CTD PMID:18412143 more ... N-acetylsphingosine multiple interactions ISO RGD:736024 6480464 N-acetylsphingosine results in increased phosphorylation of and results in increased activity of MAPK9 protein CTD PMID:18270325 N-acetylsphingosine multiple interactions ISO RGD:736023 6480464 N-acetylsphingosine results in increased phosphorylation of and results in increased activity of MAPK9 protein, TXNIP affects the reaction [N-acetylsphingosine results in increased phosphorylation of and results in increased activity of MAPK9 protein] CTD PMID:18270325 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:736024 6480464 MAPK9 inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PMAIP1 mRNA] CTD PMID:23593480 N-methyl-4-phenylpyridinium increases activity ISO RGD:736024 6480464 1-Methyl-4-phenylpyridinium results in increased activity of MAPK9 protein CTD PMID:11181820 N-methyl-4-phenylpyridinium increases phosphorylation ISO RGD:736023 6480464 1-Methyl-4-phenylpyridinium results in increased phosphorylation of MAPK9 protein CTD PMID:20946892 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:736023 6480464 8-phenyl-6a more ... CTD PMID:20946892 N-methyl-4-phenylpyridinium increases expression ISO RGD:736023 6480464 1-Methyl-4-phenylpyridinium results in increased expression of MAPK9 mRNA CTD PMID:25234470 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO RGD:736023 6480464 Methylnitronitrosoguanidine results in increased expression of MAPK9 mRNA CTD PMID:12634122 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MAPK9 mRNA CTD PMID:17602206 N-nitrosodimethylamine multiple interactions EXP 6480464 Dimethylnitrosamine results in increased phosphorylation of and results in increased activity of MAPK9 protein CTD PMID:12971962 naringin multiple interactions ISO RGD:736024 6480464 naringin inhibits the reaction [Dietary Fats results in increased phosphorylation of MAPK9 protein] CTD PMID:22198281 nickel dichloride multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [nickel chloride results in increased phosphorylation of MAPK9 protein] CTD PMID:21843586 nickel dichloride increases phosphorylation EXP 6480464 nickel chloride results in increased phosphorylation of MAPK9 protein CTD PMID:21843586 nickel sulfate increases phosphorylation ISO RGD:736023 6480464 nickel sulfate results in increased phosphorylation of MAPK9 protein CTD PMID:15588916 , PMID:19101624 niclosamide multiple interactions ISO RGD:736024 6480464 Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased phosphorylation of MAPK9 protein] CTD PMID:28824321 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of MAPK9 mRNA CTD PMID:26776438 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of MAPK9 mRNA CTD PMID:24136188 nitroprusside decreases expression EXP 6480464 Nitroprusside results in decreased expression of MAPK9 protein modified form CTD PMID:20132804 nocodazole increases phosphorylation ISO RGD:736023 6480464 Nocodazole results in increased phosphorylation of MAPK9 protein CTD PMID:12221076 nocodazole multiple interactions ISO RGD:736023 6480464 TP53 protein affects the reaction [Nocodazole results in increased phosphorylation of MAPK9 protein] CTD PMID:12221076 notoginsenoside R1 multiple interactions EXP 6480464 notoginsenoside R1 inhibits the reaction [APP protein modified form results in increased phosphorylation of MAPK9 protein] CTD PMID:24975829 ochratoxin A decreases phosphorylation ISO RGD:736023 6480464 ochratoxin A results in decreased phosphorylation of MAPK9 protein CTD PMID:25002221 olmesartan decreases activity ISO RGD:736024 6480464 olmesartan results in decreased activity of MAPK9 protein CTD PMID:17208988 olmesartan decreases expression ISO RGD:736024 6480464 olmesartan results in decreased expression of MAPK9 protein modified form CTD PMID:17208988 osthole increases phosphorylation ISO RGD:736023 6480464 osthol results in increased phosphorylation of MAPK9 protein CTD PMID:29319219 oxidopamine increases phosphorylation EXP 6480464 Oxidopamine results in increased phosphorylation of MAPK9 protein CTD PMID:25446857 oxidopamine increases phosphorylation ISO RGD:736023 6480464 Oxidopamine results in increased phosphorylation of MAPK9 protein CTD PMID:18675900 oxidopamine multiple interactions EXP 6480464 salvin inhibits the reaction [Oxidopamine results in increased phosphorylation of MAPK9 protein] CTD PMID:25446857 oxidopamine multiple interactions ISO RGD:736023 6480464 puag-haad inhibits the reaction [Oxidopamine results in increased phosphorylation of MAPK9 protein] CTD PMID:18675900 ozone increases phosphorylation ISO RGD:736023 6480464 Ozone results in increased phosphorylation of MAPK9 protein CTD PMID:19536146 paclitaxel multiple interactions ISO RGD:736023 6480464 [esculetin co-treated with Paclitaxel] results in increased expression of MAPK9 protein more ... CTD PMID:16051289 , PMID:19944065 paclitaxel increases expression ISO RGD:736023 6480464 Paclitaxel results in increased expression of MAPK9 protein CTD PMID:16051289 paclitaxel increases expression EXP 6480464 Paclitaxel analog results in increased expression of MAPK9 mRNA CTD PMID:15585946 paracetamol multiple interactions ISO RGD:736024 6480464 Acetaminophen results in increased phosphorylation of and affects the localization of MAPK9 protein more ... CTD PMID:18700144 more ... paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MAPK9 mRNA CTD PMID:33387578 paracetamol increases phosphorylation ISO RGD:736024 6480464 Acetaminophen results in increased phosphorylation of MAPK9 protein CTD PMID:19931551 more ... paracetamol decreases expression ISO RGD:736023 6480464 Acetaminophen results in decreased expression of MAPK9 mRNA CTD PMID:27761495 paracetamol increases phosphorylation EXP 6480464 Acetaminophen results in increased phosphorylation of MAPK9 protein CTD PMID:26767949 paracetamol increases expression ISO RGD:736023 6480464 Acetaminophen results in increased expression of MAPK9 mRNA CTD PMID:21420995 , PMID:27761495 paracetamol decreases response to substance ISO RGD:736024 6480464 MAPK9 results in decreased susceptibility to Acetaminophen CTD PMID:18586006 paracetamol increases response to substance ISO RGD:736024 6480464 MAPK9 protein results in increased susceptibility to Acetaminophen CTD PMID:18700144 paraquat multiple interactions ISO RGD:736023 6480464 MFN2 inhibits the reaction [Paraquat results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:17018646 more ... paraquat increases phosphorylation ISO RGD:736023 6480464 Paraquat results in increased phosphorylation of MAPK9 protein CTD PMID:28474156 paraquat increases phosphorylation ISO RGD:736024 6480464 Paraquat results in increased phosphorylation of MAPK9 protein CTD PMID:28215578 paraquat increases expression EXP 6480464 Paraquat results in increased expression of MAPK9 mRNA CTD PMID:18198484 paraquat increases phosphorylation EXP 6480464 Paraquat results in increased phosphorylation of MAPK9 protein CTD PMID:16687388 , PMID:28474156 paraquat multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Paraquat results in increased phosphorylation of MAPK9 protein] CTD PMID:16687388 , PMID:28474156 parthenolide increases expression ISO RGD:736023 6480464 parthenolide results in increased expression of MAPK9 mRNA CTD PMID:16921510 PCB138 affects expression ISO RGD:736023 6480464 2 more ... CTD PMID:21703328 Pentoxifylline increases expression ISO RGD:736023 6480464 Pentoxifylline results in increased expression of MAPK9 protein, Pentoxifylline results in increased expression of MAPK9 protein modified form CTD PMID:20804743 phenylephrine multiple interactions ISO RGD:736024 6480464 MAPK10 protein affects the reaction [MAPK9 protein affects the susceptibility to Phenylephrine] CTD PMID:16949803 phenylephrine increases phosphorylation EXP 6480464 Phenylephrine results in increased phosphorylation of MAPK9 protein CTD PMID:10727428 phenylephrine affects response to substance ISO RGD:736024 6480464 MAPK9 protein affects the susceptibility to Phenylephrine CTD PMID:16949803 phlorizin decreases expression ISO RGD:736024 6480464 Phlorhizin results in decreased expression of MAPK9 mRNA CTD PMID:22538082 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:736024 6480464 Chenodeoxycholic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:17693661 , PMID:25496033 phorbol 13-acetate 12-myristate increases phosphorylation ISO RGD:736024 6480464 Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein CTD PMID:17693661 more ... phorbol 13-acetate 12-myristate increases phosphorylation ISO RGD:736023 6480464 Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein CTD PMID:16838270 more ... phorbol 13-acetate 12-myristate multiple interactions ISO RGD:736023 6480464 CBR1 protein modified form inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:19447859 more ... phorone multiple interactions ISO RGD:736024 6480464 [phorone co-treated with tert-Butylhydroperoxide] results in increased phosphorylation of MAPK9 protein CTD PMID:20423716 phosgene multiple interactions EXP 6480464 ethyl pyruvate inhibits the reaction [Phosgene results in increased phosphorylation of MAPK9 protein] CTD PMID:21818760 phosgene increases phosphorylation EXP 6480464 Phosgene results in increased phosphorylation of MAPK9 protein CTD PMID:21818760 phthalic anhydride increases phosphorylation ISO RGD:736023 6480464 phthalic anhydride results in increased phosphorylation of MAPK9 protein CTD PMID:27129696 phthalic anhydride multiple interactions ISO RGD:736023 6480464 phthalic anhydride inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] CTD PMID:27129696 platycodin D increases activity ISO RGD:736023 6480464 platycodin D results in increased activity of MAPK9 protein CTD PMID:20412017 poly(I:C) multiple interactions EXP 6480464 [Poly I-C co-treated with HU 211] results in decreased expression of MAPK9 mRNA CTD PMID:26923065 potassium chloride multiple interactions ISO RGD:736024 6480464 MAPK10 protein affects the reaction [MAPK9 protein affects the susceptibility to Potassium Chloride] CTD PMID:16949803 pramipexole multiple interactions EXP 6480464 pramipexole inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MAPK9 protein] CTD PMID:16362428 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of MAPK9 mRNA CTD PMID:19162173 proanthocyanidin multiple interactions EXP 6480464 Proanthocyanidins inhibits the reaction [lead acetate results in increased phosphorylation of MAPK9 protein] CTD PMID:25088297 prodigiosin decreases phosphorylation ISO RGD:736023 6480464 Prodigiosin results in decreased phosphorylation of MAPK9 protein CTD PMID:31077745 progesterone increases expression EXP 6480464 Progesterone results in increased expression of MAPK9 mRNA CTD PMID:17170212 prostaglandin F2alpha increases phosphorylation ISO RGD:736024 6480464 Dinoprost results in increased phosphorylation of MAPK9 protein CTD PMID:24333336 prostaglandin F2alpha multiple interactions ISO RGD:736024 6480464 resveratrol inhibits the reaction [Dinoprost results in increased phosphorylation of MAPK9 protein], SRT1720 inhibits the reaction [Dinoprost results in increased phosphorylation of MAPK9 protein] CTD PMID:24333336 protein kinase inhibitor multiple interactions ISO RGD:736023 6480464 Protein Kinase Inhibitors inhibits the reaction [tricarbonyldichlororuthenium (II) dimer results in increased phosphorylation of MAPK9 protein] CTD PMID:26385185 protein kinase inhibitor multiple interactions EXP 6480464 Protein Kinase Inhibitors inhibits the reaction [cobaltous chloride results in increased phosphorylation of MAPK9 protein] CTD PMID:21925238 pterostilbene multiple interactions ISO RGD:736023 6480464 pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein], pterostilbene results in decreased phosphorylation of and results in decreased activity of MAPK9 protein CTD PMID:19447859 , PMID:24154491 puerarin increases phosphorylation ISO RGD:736023 6480464 puerarin results in increased phosphorylation of MAPK9 protein CTD PMID:21884717 pyrrolidine dithiocarbamate multiple interactions EXP 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased phosphorylation of MAPK9 protein more ... CTD PMID:22085843 pyrrolidine dithiocarbamate multiple interactions ISO RGD:736023 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK9 protein] CTD PMID:15557793 quercetin multiple interactions ISO RGD:736023 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:14688022 more ... quercetin increases phosphorylation ISO RGD:736023 6480464 Quercetin results in increased phosphorylation of MAPK9 protein CTD PMID:14688022 more ... quercetin increases expression ISO RGD:736023 6480464 Quercetin results in increased expression of MAPK9 protein modified form CTD PMID:19017364 reactive oxygen species multiple interactions ISO RGD:736023 6480464 [Lipopolysaccharides results in increased abundance of Reactive Oxygen Species] which results in increased phosphorylation of MAPK9 protein more ... CTD PMID:21135414 , PMID:21391979 resiniferatoxin increases activity ISO RGD:736023 6480464 resiniferatoxin results in increased activity of MAPK9 protein CTD PMID:9580328 resveratrol decreases phosphorylation ISO RGD:736023 6480464 resveratrol results in decreased phosphorylation of MAPK9 protein CTD PMID:23437203 resveratrol multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [Resveratrol results in decreased expression of MAPK9 protein modified form], Resveratrol inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of MAPK9 protein modified form] CTD PMID:27093858 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of MAPK9 protein modified form CTD PMID:27093858 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of MAPK9 mRNA CTD PMID:19228061 resveratrol increases phosphorylation ISO RGD:736023 6480464 resveratrol results in increased phosphorylation of MAPK9 protein CTD PMID:18347188 resveratrol multiple interactions ISO RGD:736023 6480464 pyrazolanthrone inhibits the reaction [resveratrol results in increased phosphorylation of MAPK9 protein], resveratrol results in increased phosphorylation of and results in increased activity of MAPK9 protein CTD PMID:18222423 , PMID:18347188 resveratrol multiple interactions ISO RGD:736024 6480464 [resveratrol results in increased activity of MAPK9 protein] which results in increased phosphorylation of and results in increased activity of TRP53 protein more ... CTD PMID:11933078 more ... resveratrol increases activity ISO RGD:736024 6480464 resveratrol results in increased activity of MAPK9 protein CTD PMID:11933078 Ro 31-8220 multiple interactions EXP 6480464 Ro 31-8220 inhibits the reaction [Arsenic results in decreased phosphorylation of and results in decreased activity of MAPK9 protein] CTD PMID:11756236 rosmarinic acid decreases phosphorylation EXP 6480464 rosmarinic acid results in decreased phosphorylation of MAPK9 protein CTD PMID:28789951 rotenone increases activity ISO RGD:736024 6480464 Rotenone results in increased activity of MAPK9 protein CTD PMID:11181820 rotenone increases phosphorylation ISO RGD:736023 6480464 Rotenone results in increased phosphorylation of MAPK9 protein CTD PMID:32368861 rotenone increases expression ISO RGD:736023 6480464 Rotenone results in increased expression of MAPK9 mRNA CTD PMID:32368861 rotenone increases phosphorylation EXP 6480464 Rotenone results in increased phosphorylation of MAPK9 protein CTD PMID:30472438 rotenone multiple interactions EXP 6480464 1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea inhibits the reaction [Rotenone results in increased phosphorylation of MAPK9 protein] CTD PMID:30472438 rotenone multiple interactions ISO RGD:736024 6480464 Rotenone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] CTD PMID:29906494 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of MAPK9 mRNA CTD PMID:28374803 rotenone increases expression EXP 6480464 Rotenone results in increased expression of MAPK9 mRNA CTD PMID:27900601 rotenone multiple interactions ISO RGD:736023 6480464 PSME4 protein promotes the reaction [Rotenone results in increased expression of MAPK9 mRNA], Rotenone inhibits the reaction [FN1 protein modified form results in increased expression of MAPK9 protein modified form] CTD PMID:17395008 , PMID:32368861 rottlerin multiple interactions ISO RGD:736023 6480464 rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein] CTD PMID:20599481 S-butyl-DL-homocysteine (S,R)-sulfoximine decreases phosphorylation ISO RGD:736023 6480464 Buthionine Sulfoximine results in decreased phosphorylation of MAPK9 protein CTD PMID:17191120 salubrinal multiple interactions ISO RGD:736023 6480464 salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein] CTD PMID:20686688 salubrinal multiple interactions EXP 6480464 [salubrinal results in increased expression of EIF2S1 protein modified form] which results in increased phosphorylation of MAPK9 protein CTD PMID:21147958 sanguinarine multiple interactions ISO RGD:736023 6480464 pyrazolanthrone inhibits the reaction [sanguinarine results in increased phosphorylation of MAPK9 protein] CTD PMID:19135517 sanguinarine increases phosphorylation ISO RGD:736023 6480464 sanguinarine results in increased phosphorylation of MAPK9 protein CTD PMID:19135517 SB 203580 multiple interactions ISO RGD:736023 6480464 SB 203580 inhibits the reaction [4-vinyl-2 more ... CTD PMID:16818652 , PMID:30653946 selenium atom multiple interactions ISO RGD:736023 6480464 Selenium inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein] CTD PMID:26187450 serpentine asbestos multiple interactions ISO RGD:736023 6480464 Acetylcysteine inhibits the reaction [Asbestos, Serpentine results in increased phosphorylation of MAPK9 protein] CTD PMID:24735948 serpentine asbestos increases phosphorylation ISO RGD:736023 6480464 Asbestos, Serpentine results in increased phosphorylation of MAPK9 protein CTD PMID:24735948 silibinin multiple interactions ISO RGD:736023 6480464 pifithrin inhibits the reaction [Silybin results in increased phosphorylation of MAPK9 protein], pyrazolanthrone inhibits the reaction [Silybin results in increased phosphorylation of MAPK9 protein] CTD PMID:16777994 silibinin increases phosphorylation ISO RGD:736023 6480464 Silybin results in increased phosphorylation of MAPK9 protein CTD PMID:16777994 silicon dioxide increases phosphorylation ISO RGD:736024 6480464 Silicon Dioxide results in increased phosphorylation of MAPK9 protein CTD PMID:27616297 silicon dioxide increases phosphorylation ISO RGD:736023 6480464 Silicon Dioxide results in increased phosphorylation of MAPK9 protein CTD PMID:26163174 , PMID:31082419 silver atom increases phosphorylation EXP 6480464 Silver results in increased phosphorylation of MAPK9 protein CTD PMID:26702581 silver(0) increases phosphorylation EXP 6480464 Silver results in increased phosphorylation of MAPK9 protein CTD PMID:26702581 simvastatin increases activity ISO RGD:736024 6480464 Simvastatin results in increased activity of MAPK9 protein CTD PMID:15187114 sodium arsenate increases phosphorylation ISO RGD:736023 6480464 sodium arsenate results in increased phosphorylation of MAPK9 protein CTD PMID:12221076 sodium arsenite increases expression ISO RGD:736024 6480464 sodium arsenite results in increased expression of MAPK9 protein modified form CTD PMID:28757890 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of MAPK9 protein CTD PMID:27966075 sodium arsenite increases phosphorylation ISO RGD:736024 6480464 sodium arsenite results in increased phosphorylation of MAPK9 protein CTD PMID:16973625 more ... sodium arsenite affects expression ISO RGD:736024 6480464 sodium arsenite affects the expression of MAPK9 CTD PMID:25367288 sodium arsenite multiple interactions ISO RGD:736024 6480464 CDKN1B protein affects the reaction [sodium arsenite results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:16973625 more ... sodium arsenite increases phosphorylation ISO RGD:736023 6480464 sodium arsenite results in increased phosphorylation of MAPK9 protein CTD PMID:12482858 more ... sodium arsenite increases activity ISO RGD:736023 6480464 sodium arsenite results in increased activity of MAPK9 protein CTD PMID:22706169 sodium arsenite multiple interactions ISO RGD:736023 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAPK9 mRNA more ... CTD PMID:12634122 more ... sodium arsenite increases phosphorylation EXP 6480464 sodium arsenite results in increased phosphorylation of MAPK9 protein CTD PMID:11408547 more ... sodium arsenite increases activity EXP 6480464 sodium arsenite results in increased activity of MAPK9 protein CTD PMID:17658681 sodium arsenite multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Cadmium Chloride co-treated with sodium arsenite co-treated with lead acetate] results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:17658681 more ... sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of MAPK9 mRNA CTD PMID:11960910 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of MAPK9 mRNA CTD PMID:25993096 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of MAPK9 mRNA CTD PMID:12325037 sorafenib multiple interactions ISO RGD:736023 6480464 [Bortezomib co-treated with Sorafenib] results in increased phosphorylation of MAPK9 protein more ... CTD PMID:16985072 , PMID:30187994 sorafenib decreases phosphorylation ISO RGD:736023 6480464 Sorafenib results in decreased phosphorylation of MAPK9 protein CTD PMID:30187994 SR 144528 multiple interactions ISO RGD:736024 6480464 SR 144528 inhibits the reaction [Dronabinol results in increased phosphorylation of MAPK9 protein] CTD PMID:24184660 stattic multiple interactions ISO RGD:736023 6480464 stattic inhibits the reaction [arsenic trichloride results in increased phosphorylation of MAPK9 protein] CTD PMID:24434654 streptozocin multiple interactions EXP 6480464 chromium mesoporphyrin inhibits the reaction [Hemin inhibits the reaction [Streptozocin results in increased expression of MAPK9 mRNA]], Hemin inhibits the reaction [Streptozocin results in increased expression of MAPK9 mRNA] CTD PMID:19190261 streptozocin multiple interactions ISO RGD:736024 6480464 [Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAPK9 protein, Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAPK9 protein] CTD PMID:26522834 streptozocin multiple interactions ISO RGD:736023 6480464 Streptozocin inhibits the reaction [AKR1B1 protein results in increased phosphorylation of MAPK9 protein] CTD PMID:25541468 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of MAPK9 mRNA CTD PMID:19190261 sucrose multiple interactions ISO RGD:736023 6480464 [Oligosaccharides co-treated with Sucrose co-treated with Dietary Fats] affects the expression of MAPK9 mRNA CTD PMID:31181236 sulfasalazine increases phosphorylation EXP 6480464 Sulfasalazine results in increased phosphorylation of MAPK9 protein CTD PMID:15633128 sulfates multiple interactions ISO RGD:736023 6480464 [Soot co-treated with Sulfates] affects the methylation of MAPK9 promoter CTD PMID:25395096 sulfates affects methylation ISO RGD:736023 6480464 Sulfates affects the methylation of MAPK9 promoter CTD PMID:25395096 sulforaphane multiple interactions ISO RGD:736023 6480464 sulforaphane inhibits the reaction [Pyruvaldehyde results in increased phosphorylation of MAPK9 protein] more ... CTD PMID:25933243 , PMID:32387680 sunitinib increases expression ISO RGD:736023 6480464 Sunitinib results in increased expression of MAPK9 mRNA CTD PMID:31533062 superoxide increases phosphorylation ISO RGD:736024 6480464 Superoxides results in increased phosphorylation of MAPK9 protein CTD PMID:33290831 tamoxifen affects expression ISO RGD:736023 6480464 Tamoxifen affects the expression of MAPK9 mRNA CTD PMID:14699072 tamoxifen multiple interactions ISO RGD:736024 6480464 Tamoxifen inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased phosphorylation of MAPK9 protein], Tamoxifen inhibits the reaction [Dietary Fats results in increased phosphorylation of MAPK9 protein] CTD PMID:23038002 Tanshinone I multiple interactions ISO RGD:736024 6480464 tanshinone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] CTD PMID:29906494 taurine multiple interactions EXP 6480464 [[Taurine binds to Zinc] which co-treated with poly(N-vinylpyrrolidine)] results in decreased expression of MAPK9 protein modified form more ... CTD PMID:26335259 , PMID:27501764 taurine decreases expression EXP 6480464 Taurine results in decreased expression of MAPK9 protein modified form CTD PMID:27501764 taurocholic acid multiple interactions ISO RGD:736024 6480464 NR1H4 gene mutant form promotes the reaction [Taurocholic Acid results in increased phosphorylation of MAPK9 protein] CTD PMID:28505368 temozolomide decreases expression ISO RGD:736023 6480464 Temozolomide results in decreased expression of MAPK9 mRNA CTD PMID:31758290 TEMPO multiple interactions ISO RGD:736024 6480464 TEMPO inhibits the reaction [Acetaminophen results in increased phosphorylation of MAPK9 protein] CTD PMID:33290831 tert-butyl hydroperoxide multiple interactions ISO RGD:736024 6480464 [phorone co-treated with tert-Butylhydroperoxide] results in increased phosphorylation of MAPK9 protein CTD PMID:20423716 tert-butyl hydroperoxide increases phosphorylation ISO RGD:736023 6480464 tert-Butylhydroperoxide results in increased phosphorylation of MAPK9 protein CTD PMID:28063877 tert-butyl hydroperoxide multiple interactions ISO RGD:736023 6480464 LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK9 protein] CTD PMID:28063877 tetracaine multiple interactions EXP 6480464 1 more ... CTD PMID:11981161 tetracaine increases phosphorylation EXP 6480464 Tetracaine results in increased phosphorylation of MAPK9 protein CTD PMID:11981161 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of MAPK9 protein CTD PMID:18081878 tetrachloromethane multiple interactions ISO RGD:736024 6480464 Plant Extracts inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of MAPK9 protein] CTD PMID:20589743 tetrachloromethane increases phosphorylation ISO RGD:736024 6480464 Carbon Tetrachloride results in increased phosphorylation of MAPK9 protein CTD PMID:20589743 , PMID:21291945 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of MAPK9 mRNA CTD PMID:16239168 tetramethylpyrazine multiple interactions ISO RGD:736023 6480464 tetramethylpyrazine inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK9 protein] CTD PMID:26404762 thapsigargin increases phosphorylation EXP 6480464 Thapsigargin results in increased phosphorylation of MAPK9 protein CTD PMID:21147958 thimerosal increases phosphorylation ISO RGD:736023 6480464 Thimerosal results in increased phosphorylation of MAPK9 protein CTD PMID:17698513 titanium dioxide multiple interactions ISO RGD:736023 6480464 [Ferrosoferric Oxide binds to titanium dioxide] which results in increased phosphorylation of MAPK9 protein CTD PMID:30098274 titanium dioxide increases phosphorylation ISO RGD:736023 6480464 titanium dioxide results in increased phosphorylation of MAPK9 protein CTD PMID:30098274 tofacitinib multiple interactions ISO RGD:736023 6480464 tofacitinib inhibits the reaction [OSM protein results in increased phosphorylation of MAPK9 protein] CTD PMID:21548952 toluene 2,4-diisocyanate increases phosphorylation ISO RGD:736023 6480464 Toluene 2, 4-Diisocyanate results in increased phosphorylation of MAPK9 protein CTD PMID:33075463 toluene 2,4-diisocyanate multiple interactions ISO RGD:736023 6480464 pyrazolanthrone inhibits the reaction [Toluene 2, 4-Diisocyanate results in increased phosphorylation of MAPK9 protein] CTD PMID:33075463 toluene 2,4-diisocyanate increases phosphorylation ISO RGD:736024 6480464 Toluene 2, 4-Diisocyanate results in increased phosphorylation of MAPK9 protein CTD PMID:33075463 toluene 2,4-diisocyanate multiple interactions ISO RGD:736024 6480464 pyrazolanthrone inhibits the reaction [Toluene 2, 4-Diisocyanate results in increased phosphorylation of MAPK9 protein] CTD PMID:33075463 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of MAPK9 mRNA CTD PMID:19448997 trichostatin A multiple interactions ISO RGD:736023 6480464 DUSP1 mutant form inhibits the reaction [trichostatin A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein]], trichostatin A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] CTD PMID:21911040 triclosan multiple interactions ISO RGD:736023 6480464 Triclosan inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of MAPK9 protein] CTD PMID:19874453 trifluoperazine multiple interactions ISO RGD:736023 6480464 Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] CTD PMID:21544200 trifluoperazine multiple interactions ISO RGD:736024 6480464 Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] CTD PMID:21544200 trifluoperazine multiple interactions EXP 6480464 Trifluoperazine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of and results in increased activity of MAPK9 protein] CTD PMID:21544200 trimellitic anhydride increases phosphorylation ISO RGD:736023 6480464 trimellitic anhydride results in increased phosphorylation of MAPK9 protein CTD PMID:27129696 trimellitic anhydride multiple interactions ISO RGD:736023 6480464 trimellitic anhydride inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] CTD PMID:27129696 trimethyltin increases phosphorylation ISO RGD:736024 6480464 trimethyltin results in increased phosphorylation of MAPK9 protein CTD PMID:26756313 trimethyltin multiple interactions ISO RGD:736024 6480464 magnolol inhibits the reaction [trimethyltin results in increased phosphorylation of MAPK9 protein] CTD PMID:26756313 tunicamycin increases phosphorylation EXP 6480464 Tunicamycin results in increased phosphorylation of MAPK9 protein CTD PMID:21147958 tyrphostin AG 1478 multiple interactions ISO RGD:736023 6480464 RTKI cpd inhibits the reaction [Cadmium results in increased phosphorylation of MAPK9 protein] CTD PMID:26514923 ursolic acid multiple interactions EXP 6480464 2 more ... CTD PMID:27274199 valproic acid increases expression ISO RGD:736023 6480464 Valproic Acid results in increased expression of MAPK9 mRNA CTD PMID:23179753 more ... valproic acid increases phosphorylation EXP 6480464 Valproic Acid results in increased phosphorylation of MAPK9 protein CTD PMID:23378038 vincaleukoblastine multiple interactions ISO RGD:736023 6480464 TP53 protein affects the reaction [Vinblastine results in increased phosphorylation of MAPK9 protein] CTD PMID:12221076 vincaleukoblastine increases phosphorylation ISO RGD:736023 6480464 Vinblastine results in increased phosphorylation of MAPK9 protein CTD PMID:12221076 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of MAPK9 mRNA CTD PMID:19015723 vinclozolin affects expression ISO RGD:736024 6480464 vinclozolin affects the expression of MAPK9 mRNA CTD PMID:34182078 WIN 55212-2 increases phosphorylation ISO RGD:736023 6480464 (3R)-((2 more ... CTD PMID:20619260 wogonin multiple interactions ISO RGD:736024 6480464 wogonin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased phosphorylation of MAPK9 protein] CTD PMID:23362215 wortmannin multiple interactions EXP 6480464 Wortmannin inhibits the reaction [dinitrophenyl-human serum albumin conjugate results in increased phosphorylation of MAPK9 protein] CTD PMID:10611455 zinc acetate multiple interactions EXP 6480464 [Taurine co-treated with Zinc Acetate] results in decreased expression of MAPK9 protein modified form CTD PMID:27501764 zinc atom multiple interactions EXP 6480464 [[Taurine binds to Zinc] which co-treated with poly(N-vinylpyrrolidine)] results in decreased expression of MAPK9 protein modified form, [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK9 protein] CTD PMID:26335259 , PMID:27501764 zinc dichloride multiple interactions ISO RGD:736024 6480464 zinc chloride inhibits the reaction [Acetaminophen results in increased phosphorylation of MAPK9 protein] CTD PMID:20423716 zinc(0) multiple interactions EXP 6480464 [[Taurine binds to Zinc] which co-treated with poly(N-vinylpyrrolidine)] results in decreased expression of MAPK9 protein modified form, [Taurine binds to Zinc] inhibits the reaction [Doxorubicin results in increased phosphorylation of MAPK9 protein] CTD PMID:26335259 , PMID:27501764
